Samer Saouma, MD
Clinical Cardiac Electrophysiology · Staten Island, NYNPI 1386025823
Payments from drug & device makers
What this record shows
This record is dominated by grants: $22,292 of the $32,547 with a category attached, or 68.5%. 11 manufacturers reported payments, led by Medtronic at 39.8% of the total. Reporting peaked in 2022 at $20,260 and has fallen 94.1% since, to $1,202 in 2025.
Across 99 payments — averaging $328.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$13K
- Boston Scientific$11K
- Abbott$5K
- Biotronik Inc.$2K
- Biosense Webster, Inc.$367
- Atricure, Inc.$264
- plus $460 from 5 others
What the payments were for
- Grants$22,29268%
- Travel & lodging$3,94012%
- Food & beverage$5,43917%
- Education$8773%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 34 | $12,943 |
| Boston Scientific | 23 | $10,935 |
| Abbott | 11 | $5,108 |
| Biotronik Inc. | 13 | $2,471 |
| Biosense Webster, Inc. | 9 | $367 |
| Atricure, Inc. | 2 | $264 |
| AstraZeneca | 2 | $187 |
| Cardiovascular Systems Inc. | 2 | $149 |
| Cardiva Medical, Inc. | 1 | $68 |
| Kestra Medical Technology Services, Inc. | 1 | $44 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- EMBLEM MRI S-ICD$3,862
- GENERAL - THERAPIES$2,114
- VersaCross Access Solution$715
- AVEIR$300
- Acticor 7 VR-T DX$246
- BioMonitor$148
- Coronary Orbital Atherectomy System$139
- ATRICURE CRYOICE CRYOSPHERE CRYOABLATION SYSTEM$137
- AFFERA MAPPING SYSTEM$132
- ATRICURE CRYOICE CRYOABLATION SYSTEM (CRYO2)$127
- ATRICLIP LAA EXCLUSION SYSTEM$127
- AMVIA EDGE$122
- WATCHMAN Access System$115
- Carto 3$106
How this compares
$32,547 in reported general payments places this provider in the 60th percentile of 214 clinical cardiac electrophysiology providers in New York.
See all clinical cardiac electrophysiology providers in New York →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 41 | $35,946 |
| Amiodarone Hcl | 27 | $261 |
| Metoprolol Succinate | 22 | $259 |
| ClopidogrelClopidogrel Bisulfate | 16 | $162 |
| Metoprolol Tartrate | 31 | $81 |
Paid to pharmacies, not to this prescriber.
Other clinical cardiac electrophysiology in Staten Island
- Marcin KowalskiStaten Island$119K
- Valay ParikhStaten Island$49K
- Vivek ReddyNew York$14.9M
- Jacob KoruthNew York$3.7M
- Srinivas DukkipatiNew York$2.7M
- Amir AhmadiNew York$789K
- Larry ChinitzNew York$448K
- Felix YangBrooklyn$407K
- James IpNew York$347K
- Stavros MountantonakisManhasset$321K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.